什么是持股变动声明？$Olema Pharmaceuticals (OLMA.US)$ Director Graham G. Walmsley purchased 700.76K shares of common stock on Dec 13, 2024 at an average price of $6.75 for a total value of $4.73 million, and sold 700.76K shares of common stock on Dec 13, 2024 at an average price of $6.75 for a total value of $4.73 million.
What is statement of changes in beneficial ownership of securities?
It is a requirement under federal securities laws that mandates individuals, including officers, directors, and those who hold more than 10% of any class of a company's securities (collectively known as "insiders"), to report their purchases, sales, and holdings of their company's securities by submitting Forms 3, 4, and 5.
